Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
14 /100
LOW RISK
Score updated Oct 13, 2026

NEO — NeoGenomics, Inc. Dilution Risk Tracker

Track NEO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NEO — Get alerts when the score changes →

As of October 13, 2026, NeoGenomics, Inc. (NEO) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. NeoGenomics, Inc. has a market capitalization of $2.08B, 128.48M shares outstanding, 262 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NEO.
🔔 Track NEO — Get forecast alerts →

Market Data

Market Cap$2.08B
Shares Outstanding128.48M
Float118.40M
Cash$145.54M
Debt$374.24M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore14/100DilutionWatch score record
Shares Outstanding128.48MVerified float table or market cache
Public Float118.40MVerified float table or market cache
Market Cap$2.08BMarket data cache
Cash Runway24.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 11.6% shares (2026Q1 vs prior)
262 institutional holders · 151.29M shares
#1 BlackRock, Inc. 19.96M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 11.31M shares
#3 First Light Asset Management, LLC 9.73M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest14.15M
Days to Cover5.7
% of Float11.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-02-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NEO Dilution Snapshot

NeoGenomics, Inc. (NEO) has a DilutionScore of 14/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NEO's DilutionScore is currently 14/100 (Low risk), with 2 score changes tracked over 89 days. The score deteriorated from 26/100 (Medium risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202614/100LOW4 days
Aug 14 – Oct 09, 202626/100MEDIUM56 days
Jul 16 – Aug 13, 202622/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NEO shares outstanding have increased 0.3% from 129.81M (Apr 2026) to 130.21M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 28, 2026130.21M118.40M▼ 0.05%
May 18, 2026130.21M118.45M▼ 0.37%
May 10, 2026130.21M118.90M▼ 0.39%
May 02, 2026130.21M119.36M▲ 0.81%
May 01, 2026130.21M118.40M▼ 0.50%
Apr 27, 2026130.14M118.99M▼ 0.19%
Apr 11, 2026130.14M119.22M▲ 0.02%
Apr 07, 2026129.81M119.20M▼ 0.09%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NEO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NEO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NEO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NEO
NEO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.